EKR Formulation definition
Examples of EKR Formulation in a sentence
EKR believes that the EKR Formulation and Baxter Container can be developed to permit the manufacture and sale of a product that neither EKR nor Baxter could develop or manufacture independently, and such product will offer significant benefits to customers.
The Parties acknowledge that their desire to use the Baxter Container in combination with the EKR Formulation for the commercialization of the Product is contingent, for example, upon the Baxter Container being deemed compatible with the EKR Formulation.
Baxter is interested in expanding the application of the Baxter Container to the packaging of drug products that have significant usage potential, such as the EKR Formulation.
Subject to Section 13.3, the entire right, title and interest in all Inventions conceived solely by EKR or its employees, agents or other representatives (the “EKR Inventions”) will be owned solely by EKR, except that EKR hereby assigns to Baxter all EKR Inventions that relate to the Baxter Container but that does not relate to the EKR Compound or the EKR Formulation.
This section shall apply to the extent EKR acquires or has acquired the right to market the EKR Formulation outside the United States.
Baxter will promptly disclose to EKR, in English and in writing, all Baxter materials and information identified as Baxter Deliverables in the Development Plan (“▇▇▇▇▇▇ Development Deliverables;’); which include without limitation the data, test results, and specifications or procedures for the Product refined specifically for the API and/or EKR Formulation, and the results of the technical development studies and such other interim progress reports agreed upon by the Parties.
EKR and Baxter have previously signed the Prior LOI, and the Amended LOI regarding the optimization, development and manufacturing of the EKR Formulation in the Baxter Container.
Baxter will provide to EKR reports containing the data, test results, and specifications or procedures for the Product developed specifically for the EKR Compound and/or the EKR Formulation (“API/Formulation Specifications”) (and collectively, the “Project Materials”).
The parties hereby enter into a definitive agreement to provide for the collaborative development of the EKR Formulation in the Baxter Container, and manufacture of the Product in accordance with the terms and conditions set forth in this Agreement.
In the event that Baxter and EKR are unable to agree on the foregoing items, then EKR’s position will prevail as it pertains to all Communications sent to Regulatory Authorities relating to the API, EKR Formulation, and the Product, except with respect to that portion of the response that relates solely to the Baxter Container and then ▇▇▇▇▇▇’▇ position will prevail.